Abs Against Gram + Organisms 9/10/15 Flashcards
List the glycopeptide antibiotics.
Vancomycin
Dalbavancin
Telavancin
Teicoplanin and Oritavancin (little to no info given)
What is the MOA of Vancomycin?
Cell wall synthesis inhibitor
Time-dependent bactericidal activity
**Static against Enterococcus
What type of bacteria does Vancomycin target?
GRAM POSITIVE ONLY
Examples:
- MSSA/MRSA
- PRSP/other streptococcus
- Clostridium spp (inc. C. difficile)
How should Vancomycin be administered?
IV = systemic infections
Oral = C. difficile colitis
Widely distributed into body tissues/fluids/adipose tissue
Describe elimination of Vancomycin from the body.
Elimination half-life depends on renal function
+
NOT removed by hemodialysis
=
Takes a longer time to eliminate with patients on hemodialysis/renal failure
What are some clinical uses for Vancomycin?
MRSA infections:
-bacteremia, endocarditis, pneumonia, skin, meningitis
Beta-lactam allergic pts
Infections caused by multi-drug resistant bacteria (PRSP)
Moderate to severe C. diff (orally)
What are some major adverse effects of Vancomycin?
Red Man Syndrome:
- Related to rate of IV infusion
- Histamine release = erythematous rash, flushing, pruritus
Nephro/Ototoxicity:
- Common when administered with aminoglycosides
- Higher risk with renal failure, high doses, prolonged therapy
What type of bacteria are targeted by Dalbavancin (IV)?
Resistant gram positive organisms
Examples:
- MRSA/VISA
- VRE = Van B and Van C (NOT Van A)
- MRSE/Streptococcus
Compare and contrast the MOA of Dalbavancin and Vancomycin.
- Dalba is more potent/cidal than Vanco
- Work similarly to inhibit cell wall synthesis
What are some major adverse effects associated with Dalbavancin?
Anaphylaxis
Red Man infusion
Skin reactions
What dosing adjustments to Dalbavancin should be made in the following situations:
- Patient with renal insufficiency
- Patient on hemodialysis
- Decrease dose
- No adjustment needed (not cleared by HD)
Compare Telavancin to Vancomycin.
-Usage: complicated SSSI, HAP, VAP (S. aureus)
(hospital and ventilator associated pneumonia)
-AEs: GI symptoms, teratogenic, and more nephrotoxic
List the Oxazolidinones and why they were developed.
Linezolid (PO and IV)
Tedizolid (PO and IV)
-Activity against resistant gram positive orgs (VRE, MRSA, VISA)
What is the MOA of Linezolid and Tedizolid?
Inhibit Protein Synthesis
Is Linezolid bacteriostatic or cidal?
Bacteriostatic
(time-dependent bactericidal against Strep pneumo)
What is the spectrum of activity of Linezolid?
Gram Positive Bacteria ONLY
- MSSA/MRSA/VRSA
- Coagulase-negative Staphylococci
- PRSP/other Streptococci
- VRE/other Enterococci
- NO C. diff
Describe A, D and E of Linezolid.
Absorption: 100% bioavailable
Distribution: readily penetrates well-perfused tissue (30% CSF)
Elimination: Renally and non-renally = NO adjustment for RI and removed by HD
What is Linezolid used for clinically?
Very expensive = Serious/complicated infections caused by resistant gram positive bacteria
- VRE = bacteremia
- MSSA/MRSA/Strep pyogenes = Complicated skin/soft tissue infections
- MRSA = Nosocomial pneumonia
NOT for UTIs
What drugs interactions occur with Linezolid and what are the effects?
SSRIs/MAOIs
Serotonin Syndrome:
- hyperpyrexia
- cognitive dysfunction
- seizures
- coma
Compare and contrast major adverse effects of Linezolid and Tedizolid.
Similarities:
Nausea, vomiting, diarrhea
Peripheral neuropathy
Differences:
Linezolid = lactic acidosis/thrombocytopenia/anemia
Tedizolid = NO SSRI interaction, dizziness, hematologic, optic neuropathy
What are the lipopeptide antibiotics and why were they created?
Daptomycin
Quinupristin-Dalfopristin
-Resistant gram positive orgs
What is the MOA of Daptomycin?
Inhibits Protein, RNA and DNA synthesis
Concentration-dependent bactericidal activity
List the spectrum of activity and clinical uses for Daptomycin.
Very expensive = Serious/complicated infections caused by Resistant Gram Positive Bacteria:
- MSSA/MRSA/VRSA = skin/soft tissue infections and bacteremia
- CNSt
- PRSP/other streptococci
- VRE/other enterococci = endocarditis, meningitis, osteo
NOT for pneumonia
Describe D and E for Daptomycin (IV).
Distribution: readily distributes to well-perfused tissue, 90% protein binding
Elimination: primarily by kidneys,
adjust dose for RI,
NOT removed by HD
What are adverse effects and drug interactions for Daptomycin?
AEs: GI, H/a, Injection site reaction, Rash, myopathy
DIs: HMG CoA-reductase inhibitors (increased myopathy)
Describe the MOA, Elimination and AEs of Quinupristin-Dalfopristin.
Protein synthesis inhibitors
synergistic effect = Cidal
Cleared by liver
AEs: severe GI intolerance = not often used
Jaundice